Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Med Phys ; 27(2): 359-67, 2000 Feb.
Article in English | MEDLINE | ID: mdl-10718140

ABSTRACT

A modified neutron production target assembly has been developed to provide improved performance of the proton-cyclotron-based neutron radiotherapy facility at the University of Washington for applications involving neutron capture enhanced fast-neutron therapy. The new target produces a neutron beam that yields essentially the same fast-neutron physical depth-dose distribution as is produced by the current UW clinical system, but that also has an increased fraction of BNCT enhancement relative to the total therapeutic dose. The modified target is composed of a 5-millimeter layer of beryllium, followed by a 2.5-millimeter layer of tungsten, with a water-cooled copper backing. Measurements of the free-field neutron spectrum of the beam produced by the new target were performed using activation foils with a direct spectral unfolding technique. Water phantom measurements were performed using a tissue-equivalent ion chamber to characterize the fast-neutron depth-dose curve and sodium activation in soda-lime glass beads to characterize the thermal-neutron flux (and thus the expected neutron capture dose enhancement) as a function of depth. The results of the various measurements were quite consistent with expectations based on the design calculations for the modified target. The spectrum of the neutron beam produced by the new target features an enhanced low-energy flux component relative to the spectrum of the beam produced by the standard UW target. However, it has essentially the same high-energy neutron flux, with a reduced flux component in the mid-range of the energy spectrum. As a result, the measured physical depth-dose curve in a large water phantom has the same shape compared to the case of the standard UW clinical beam, but approximately twice the level of BNCT enhancement per unit background neutron dose at depths of clinical interest. In-vivo clinical testing of BNCT-enhanced fast-neutron therapy for canine lung tumors using the new beam was recently initiated.


Subject(s)
Boron Neutron Capture Therapy , Fast Neutrons/therapeutic use , Animals , Boron Neutron Capture Therapy/instrumentation , Cyclotrons , Dog Diseases/radiotherapy , Dogs , Equipment Design , Hospitals, University , Humans , Image Enhancement , Lung Neoplasms/radiotherapy , Lung Neoplasms/veterinary , Phantoms, Imaging , Radiation Oncology , Washington , Water
2.
Med Phys ; 27(1): 192-202, 2000 Jan.
Article in English | MEDLINE | ID: mdl-10659757

ABSTRACT

Advanced methods of boron neutron capture therapy (BNCT) use an epithermal neutron beam in conjunction with tumor-targeting boron compounds for irradiation of glioblastomas and metastatic melanomas. A common neutron-producing reaction considered for accelerator-based BNCT is 7Li(p,n)7Be, whose cross section increases very rapidly within several tens of keV of the reaction threshold at 1.88 MeV. Operation in the proton energy region near threshold will have an appreciable thick target neutron yield, but the neutrons produced will have relatively low energies that require little moderation to reach the epithermal range desirable for BNCT. Because of its relatively low projected accelerator cost and the portability of the neutron source/target assembly, BNCT based on the near-threshold technique is considered an attractive candidate for widespread hospital use. A systematic Monte Carlo N-Particle (MCNP) investigation of the dosimetric properties of near-threshold neutron beams has been performed. Results of these studies indicate that accelerator proton energies between 1.93 and 1.99 MeV, using 5 cm of H2O moderator followed by thin 6Li and Pb shields, can provide therapeutically useful beams with treatment times less than one hour and accelerator currents less than 5 mA.


Subject(s)
Boron Neutron Capture Therapy/methods , Radiotherapy Planning, Computer-Assisted/statistics & numerical data , Beryllium , Biophysical Phenomena , Biophysics , Boron Neutron Capture Therapy/statistics & numerical data , Glioblastoma/radiotherapy , Humans , Lithium , Melanoma/radiotherapy , Melanoma/secondary , Monte Carlo Method , Photons , Radioisotopes
3.
Basic Life Sci ; 54: 235-45, 1990.
Article in English | MEDLINE | ID: mdl-2268243

ABSTRACT

Neutron spectrum measurements were performed on the aluminum oxide filter installed in the Brookhaven Medical Research Reactor (BMRR). For these measurements, activation foils were irradiated at the exit port of the beam facility. A technique based on dominant resonances in selected activation reactions was used to measure the epithermal neutron spectrum. The fast and intermediate-energy ranges of the neutron spectrum were measured by threshold reactions and 10B-shielded 235U fission reactions. Neutron spectral data were derived from the activation data by two approaches: (1) a short analysis which yields neutron flux values at the energies of the dominant or primary resonances in the epithermal activation reactions and integral flux data for neutrons above corresponding threshold or pseudo-threshold energies, and (2) the longer analysis which utilized all the activation data in a full-spectrum, unfolding process using the FERRET spectrum adjustment code. This paper gives a brief description of the measurement techniques, analysis methods, and the results obtained.


Subject(s)
Neutrons/therapeutic use , Nuclear Reactors/instrumentation , Aluminum Oxide , Animals , Biophysical Phenomena , Biophysics , Dogs , Filtration , Radiotherapy Dosage , Spectrum Analysis , Statistics as Topic
4.
Appl Opt ; 8(12): 2563-4, 1969 Dec 01.
Article in English | MEDLINE | ID: mdl-20076082
SELECTION OF CITATIONS
SEARCH DETAIL
...